Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;13(1):44-52.
doi: 10.1007/s11904-016-0301-4.

Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults

Robert C Kaplan  1 , David B Hanna  2 , Jorge R Kizer  2   3
Affiliations
Review

Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults

Robert C Kaplan et al. Curr HIV/AIDS Rep. 2016 Feb.

Abstract

While mortality rates related to cardiovascular disease (CVD) have decreased over time among adults with HIV, excess risk of CVD in the HIV-infected population may persist despite highly active antiretroviral therapy (HAART) treatment and aggressive CVD risk factor control. Beyond atherosclerotic CVD, recent studies suggest that HIV infection may be associated with left ventricular systolic and diastolic function, interstitial myocardial fibrosis, and increased cardiac fat infiltration. Thus, with the increasing average age of the HIV-infected population, heart failure and arrhythmic disorders may soon rival coronary artery disease as the most prevalent forms of CVD. Finally, the question of whether HIV infection should be considered in clinical risk stratification has never been resolved, and this question has assumed new importance with recent changes to lipid treatment guidelines for prevention of CVD.

Keywords: Aging; CVD; Cardiovascular disease; Coronary heart disease; Epidemiology; HIV; HIV/AIDS; Review.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Robert C. Kaplan, David B. Hanna, Jorge R. Kizer declare that they have no conflict of interest.

References

    1. Palella FJ, Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. The New England journal of medicine. 1998;338(13):853–60. - PubMed
    1. Wada N, Jacobson LP, Cohen M, et al. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984–2008. American journal of epidemiology. 2013;177(2):116–25. - PMC - PubMed
    1. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PloS one. 2013;8(12):e81355. - PMC - PubMed
    1. INSIGHT START Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. The New England journal of medicine. 2015 - PMC - PubMed
    1. Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet (London, England) 2010;376(9734):49–62. - PubMed

MeSH terms

Substances

LinkOut - more resources